Dr Léonard Kouegnigan Rerambiah takes over the “house” – Archyde

Dr Léonard Kouegnigan Rerambiah takes over the “house” - Archyde

@media screen and (min-width: 1201px) {
.sbdlh65e1a0a4a6295 {
display: block;
}
}
@media screen and (min-width: 993px) and (max-width: 1200px) {
.sbdlh65e1a0a4a6295 {
display: block;
}
}
@media screen and (min-width: 769px) and (max-width: 992px) {
.sbdlh65e1a0a4a6295 {
display: block;
}
}
@media screen and (min-width: 768px) and (max-width: 768px) {
.sbdlh65e1a0a4a6295 {
display: block;
}
}
@media screen and (max-width: 767px) {
.sbdlh65e1a0a4a6295 {
display: block;
}
}

Medical biologist, Dr Léonard Kouegnigan Rerambiah, former head of the medical biology department at Chul, returns to an administration that he had already headed twice, from 2005 to 2008 and from 2011 to 2014; before handing over to his Deputy, Dr Jophrette Mireille Ntsame Ndong, who had also been Director of the Cnts between 2014 and 2018.

2024-02-29 13:09:53
#Léonard #Kouegnigan #Rerambiah #takes #house
Source : CTNS
Promoted, at the same time as his Deputy, Dr Jophette Mireille Ntsame Ndong, following the Council of Ministers on February 24, Dr Léonard Kouegnigan Rerambiah officially took office on February 29, 2024, during a supervised ceremony. by the Deputy Secretary General of the Ministry of Health, Dr Élise Eyang Obame.
The first major project for him concerns the extension and regionalization program of the Cnts, the first milestones of which were laid by his predecessor, Dr Marie-Thérèse Vané Ndong-Obiang, warmly accompanied by his former colleagues.

The new Director of the National Blood Transfusion Center (Cnts), grateful to the appointing authority, the President of the transition in this case, did not fail to indicate on the occasion, his determination to redouble his hard work to deserve the trust that is thus placed in him.

@media screen and (min-width: 1201px) {
.obdhq65e1a0a4a6240 {
display: block;
}
}
@media screen and (min-width: 993px) and (max-width: 1200px) {
.obdhq65e1a0a4a6240 {
display: block;
}
}
@media screen and (min-width: 769px) and (max-width: 992px) {
.obdhq65e1a0a4a6240 {
display: block;
}
}
@media screen and (min-width: 768px) and (max-width: 768px) {
.obdhq65e1a0a4a6240 {
display: block;
}
}
@media screen and (max-width: 767px) {
.obdhq65e1a0a4a6240 {
display: block;
}
}

Related posts:

@media screen and (min-width: 1201px) {
.hymvx65e1a0a4a61d7 {
display: block;
}
}
@media screen and (min-width: 993px) and (max-width: 1200px) {
.hymvx65e1a0a4a61d7 {
display: block;
}
}
@media screen and (min-width: 769px) and (max-width: 992px) {
.hymvx65e1a0a4a61d7 {
display: block;
}
}
@media screen and (min-width: 768px) and (max-width: 768px) {
.hymvx65e1a0a4a61d7 {
display: block;
}
}
@media screen and (max-width: 767px) {
.hymvx65e1a0a4a61d7 {
display: block;
}
}

Share this post :

Facebook
Twitter
LinkedIn
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News